Dental Pain: Clinical Trials

16 trials for Dental Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 1 recruiting, 1 terminated, 1 withdrawn. 16 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 216Completed 13, Recruiting 1, Terminated 1, Withdrawn 1
Phase 11Recruiting 1

Follow Dental Pain: new trials by email Literature Review of Dental Pain trials Research Report on Dental Pain

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction
CYT-1010, Placebo - Acute Postoperative Pain, Dental Pain
Phase 1 / Phase 2RecruitingCytogel Pharma, LLC322026-09-252026-10-29
A Study of Acetaminophen for Post Surgical Dental Pain
Acetaminophen, Placebo - Pain, Postoperative, Dental Pain
Phase 2CompletedNevakar, Inc.1102019-04-252022-03-29
The Impact of Minimally Invasive Restorative Techniques on Dental Pain in Pregnant Women
Papacarie, Atraumatic Restorative Treatment - Dental Pain, Patient Satisfaction
Phase 2CompletedNourhan M.Aly1622019-01-102020-10-05
Dental Pain Study of Analgesics in Patients Undergoing Molar Removal
Pre-Op pregabalin, Pre-Op Placebo 1, Post-Op pregabalin - Dental Pain
Phase 2CompletedNevakar, Inc.1152018-06-152021-11-23
Study of Acetaminophen (ACE) in Post-operative Dental Pain
Acetaminophen (ACE) (1000 mg), Commercial ACE (1000 mg), Commercial Ibuprofen (IBU) (400 mg) - Dental Pain
Phase 2CompletedJohnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.2402014-12-312021-12-03
Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
NTC-510 capsules, Placebo Capsules, NTC-510A Capsules - Dental Pain
Phase 2TerminatedNanoSHIFT LLC522014-06-012017-06-23
Study of Long-Acting Acetaminophen in Postoperative Dental Pain
Acetaminophen ER, Placebo - Dental Pain
Phase 2CompletedMcNeil Consumer Healthcare Division of McNEIL-PPC, Inc.4032013-10-012015-07-10
Study of Naproxen Capsules to Treat Dental Pain
Naproxen Test, Naprosyn, Placebo - Dental Pain
Phase 2CompletedIroko Pharmaceuticals, LLC2542010-10-012012-05-22
Study of Diclofenac Capsules to Treat Dental Pain
Diclofenac Test (lower dose), Diclofenac Test (upper dose), Celecoxib 400 mg - Dental Pain
Phase 2CompletedIroko Pharmaceuticals, LLC2022009-09-012012-05-22
Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction
XPF-001, placebo - Dental Pain
Phase 2CompletedXenon Pharmaceuticals Inc.612009-09-012012-07-16
Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain
Oxycodone, Buprenorphine, Placebo Film - Dental Pain
Phase 2CompletedBioDelivery Sciences International1532009-08-012017-02-27
Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
Celecoxib 400 mg, Placebo, Indomethacin Test (lower dose) - Dental Pain
Phase 2CompletedIroko Pharmaceuticals, LLC2032009-08-012012-05-22
Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery
N1539, placebo, Motrin - Dental Pain
Phase 2CompletedAlkermes, Inc.2302009-07-012011-12-02
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Placebo; oral, ARRY-371797, p38 inhibitor; oral, Celecoxib, COX-2 inhibitor; oral - Dental Pain
Phase 2CompletedPfizer2502008-04-072021-02-09
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
ARRY-371797, p38 inhibitor; oral, Placebo; oral - Dental Pain
Phase 2CompletedPfizer1032007-11-112021-02-21
Maxi-Analgesic Phase 2 Study to Compare the Analgesic Effects in Different Dosing Groups to Treat Teeth Extraction Pain
Full Dose Strength, Quarter dose strength, Half dose strength - Dental Pain
Phase 2WithdrawnAFT Pharmaceuticals, Ltd.2013-07-12

Narrower conditions

Toothache (16)  ·  Pain, Postoperative (3)  ·  Agnosia (2)  ·  Acute Pain (1)  ·  Pain (1)  ·  Patient Satisfaction (1)

Broader conditions

Facial Pain (16)  ·  Neurologic Manifestations (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Signs and Symptoms (16)  ·  Stomatognathic Diseases (16)  ·  Tooth Diseases (16)  ·  Pain (15)  ·  Pathologic Processes (3)  ·  Postoperative Complications (3)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Perceptual Disorders (2)  ·  Behavior (1)  ·  Health Behavior (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Acetaminophen (3)  ·  Celecoxib (3)  ·  ARRY-371797 (2)  ·  Buprenorphine (2)  ·  Ibuprofen (2)  ·  Cyclooxygenase 2 Inhibitors (1)  ·  Dental Atraumatic Restorative Treatment (1)  ·  Meloxicam (1)  ·  Naloxone (1)  ·  Naproxen (1)  ·  Oxycodone (1)  ·  Papacarie (1)  ·  Sugars (1)

Sponsors

Iroko Pharmaceuticals, LLC (3)  ·  Nevakar, Inc. (2)  ·  Pfizer (2)  ·  AFT Pharmaceuticals, Ltd. (1)  ·  Alkermes, Inc. (1)  ·  BioDelivery Sciences International (1)  ·  Cytogel Pharma, LLC (1)  ·  Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. (1)  ·  McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (1)  ·  NanoSHIFT LLC (1)  ·  Nourhan M.Aly (1)  ·  Xenon Pharmaceuticals Inc. (1)

Countries

United States (15)  ·  Egypt (1)

Top investigators

Steven Christensen, DDS (2)  ·  David Blum, MD (1)  ·  Eric Lang, MD (1)  ·  Kenneth Somberg, MD (1)  ·  May M Adham, M.Sc (1)  ·  Michael Kuss, Doctor (1)  ·  Mona K ElKashlan, PhD (1)  ·  Todd Bertoch (1)  ·  Wafaa E Abdelaziz, PhD (1)  ·  William L Buchanan, MD,DDS (1)

Results publications

PMID 24127200, PMID 29329493, PMID 30737315, PMID 33602209